Human Papillomavirus-Negative Neck Squamous Cell Carcinoma: Clinical Trials

1 trial for Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Human Papillomavirus-Negative Neck Squamous Cell Carcinoma: new trials by email Literature Review of Human Papillomavirus-Negative Neck Squamous Cell Carcinoma trials Research Report on Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Biospecimen Collection, Chemotherapy, Decitabine - Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingMayo Clinic322026-01-232026-07-15

Interventions

Congresses as Topic (1)  ·  Decitabine (1)  ·  Drug Therapy (1)  ·  Injections (1)  ·  Radiation (1)  ·  Specimen Handling (1)  ·  Surgical Procedures, Operative (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Adam L. Holtzman, MD (1)